Asarina Pharma AB publ announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced operating loss was SEK 17.535 million compared to SEK 21.786 million a year ago. Net loss was SEK 17.561 million compared to SEK 19.973 million a year ago. For the nine months, operating loss was SEK 56.494 million compared to SEK 60.667 million a year ago. Net loss was SEK 56.609 million compared to SEK 55.223 million a year ago.